Published in Semin Intervent Radiol on December 01, 2010
An integrated safety analysis of intravenous ibuprofen (Caldolor(®)) in adults. J Pain Res (2015) 0.75
Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med (2008) 6.48
Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A (2002) 4.80
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med (1998) 4.24
Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology (2006) 3.81
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation (2006) 2.58
Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 2.55
Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol (2009) 2.52
Treatment of neuropathic pain: an overview of recent guidelines. Am J Med (2009) 2.43
Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain (2008) 2.38
Pharmacologic treatment of cancer pain. N Engl J Med (1996) 2.24
Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain (2003) 2.18
Postoperative epidural opioid analgesia: what are the choices? Anesth Analg (1996) 2.15
75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol (2006) 1.91
Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol (2008) 1.84
Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev (2008) 1.82
Opioid metabolism. Mayo Clin Proc (2009) 1.76
RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell Signal (2005) 1.69
Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med (1998) 1.66
Opioid receptors in the gastrointestinal tract. Regul Pept (2009) 1.64
Complicated pain management in a CYP450 2D6 poor metabolizer. Pain Pract (2007) 1.58
Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med (2007) 1.56
Mechanism of action of nonsteroidal anti-inflammatory drugs. Cancer Invest (1998) 1.51
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol (2009) 1.45
Paracetamol (Acetaminophen): mechanisms of action. Paediatr Anaesth (2008) 1.34
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta. Neuroscience (2010) 1.33
Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J Neurosci (2005) 1.33
Opioids in neuropathic pain. Curr Pharm Des (2005) 1.25
Absorption characteristics of transdermally administered fentanyl. Anesthesiology (1989) 1.17
Stimulating the development of mechanism-based, individualized pain therapies. Nat Rev Drug Discov (2007) 1.08
Adjuvant analgesics in cancer pain management. Oncologist (2004) 1.08
Differential regulation of renal cyclooxygenase mRNA by dietary salt intake. Kidney Int (1997) 1.02
Principles of control of cancer pain. BMJ (2006) 1.01
Comparison of intravenous nalbuphine infusion versus naloxone in the prevention of epidural morphine-related side effects. Reg Anesth Pain Med (1998) 1.01
Brief history of antipyretic therapy. Clin Infect Dis (2000) 1.01
Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain (2002) 0.97
Opioid-induced abnormal pain sensitivity. Curr Pain Headache Rep (2006) 0.95
Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation. J Biol Chem (2009) 0.95
Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects. Brain Behav Immun (2009) 0.95
Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease. Am J Physiol Renal Physiol (2007) 0.92
Pain medicine position paper. Pain Med (2009) 0.91
The development of gastrointestinal-sparing nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci (1994) 0.90
Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade. Psychopharmacology (Berl) (2007) 0.90
Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag (2008) 0.89
G protein inactive and active forms investigated by simulation methods. Proteins (2009) 0.88
Reye's syndrome: the case for a causal link with aspirin. Drug Saf (2006) 0.87
NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage (2000) 0.86
The molecular toxicology of acetaminophen. Drug Metab Rev (2005) 0.85
Pharmacological aspects of successful long-term analgesia. Clin Rheumatol (2006) 0.84
New approaches to the treatment of opioid-induced constipation. Eur Rev Med Pharmacol Sci (2008) 0.83
Endogenous opiates and behavior: 2008. Peptides (2009) 0.83
The role of methadone in opioid rotation-a Polish experience. Support Care Cancer (2008) 0.82
Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. J Pharm Pharm Sci (2004) 0.82
New culprits in chronic pain. Sci Am (2009) 0.81
Choosing nonselective NSAIDs and selective COX-2 inhibitors in the elderly. A clinical use pathway. Geriatrics (2007) 0.78
Prescribing methadone, a unique analgesic. J Support Oncol (2004) 0.77
Adenosine contributes to mu-opioid synaptic inhibition in rat substantia gelatinosa in vitro. Neurosci Lett (2004) 0.76
A team approach to neuroscience nursing critical care orientation. J Neurosci Nurs (2006) 0.75